BTN2A2
Butyrophilin subfamily 2 member A2
Also known as: BT2.2, BT2A2_HUMAN, BTF2, BTN2.2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WVV5
- Gene
- BTN2A2
- Ensembl
- ENSG00000124508
- Chromosome
- 6
- Canonical length
- 523 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
OverviewNCBI Gene
Butyrophilin is the major protein associated with fat droplets in the milk. This gene is a member of the BTN2 subfamily of genes, which encode proteins belonging to the butyrophilin protein family. The gene is located in a cluster on chromosome 6, consisting of seven genes belonging to the expanding B7/butyrophilin-like group, a subset of the immunoglobulin gene superfamily. The encoded protein is a type I receptor glycoprotein involved in lipid, fatty-acid and sterol metabolism. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
Canonical amino-acid sequenceUniProt
523 residues, UniProt reviewed canonical sequence.
>Q8WVV5|BTN2A2
1 MEPAAALHFS LPASLLLLLL LLLLSLCALV SAQFTVVGPA NPILAMVGEN TTLRCHLSPE
61 KNAEDMEVRW FRSQFSPAVF VYKGGRERTE EQMEEYRGRI TFVSKDINRG SVALVIHNVT
121 AQENGIYRCY FQEGRSYDEA ILRLVVAGLG SKPLIEIKAQ EDGSIWLECI SGGWYPEPLT
181 VWRDPYGEVV PALKEVSIAD ADGLFMVTTA VIIRDKYVRN VSCSVNNTLL GQEKETVIFI
241 PESFMPSASP WMVALAVILT ASPWMVSMTV ILAVFIIFMA VSICCIKKLQ REKKILSGEK
301 KVEQEEKEIA QQLQEELRWR RTFLHAADVV LDPDTAHPEL FLSEDRRSVR RGPYRQRVPD
361 NPERFDSQPC VLGWESFASG KHYWEVEVEN VMVWTVGVCR HSVERKGEVL LIPQNGFWTL
421 EMFGNQYRAL SSPERILPLK ESLCRVGVFL DYEAGDVSFY NMRDRSHIYT CPRSAFTVPV
481 RPFFRLGSDD SPIFICPALT GASGVMVPEE GLKLHRVGTH QSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BTN2A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 34 nTPM
- lymph node: 30 nTPM
- choroid plexus: 28 nTPM
- appendix: 21 nTPM
- spleen: 21 nTPM
- cerebellum: 18 nTPM
Single-cell type
- mast cells: 58 nCPM
- cdc: 44 nCPM
- plasma cells: 44 nCPM
- b-cells: 33 nCPM
- choroid plexus epithelial cells: 27 nCPM
- kupffer cells: 23 nCPM
Immune cell
- naive B-cell: 30 nTPM
- memory B-cell: 24 nTPM
- myeloid DC: 24 nTPM
- intermediate monocyte: 15 nTPM
- classical monocyte: 14 nTPM
- neutrophil: 12 nTPM
Brain region
- choroid plexus: 41 nTPM
- cerebellum: 26 nTPM
- pons: 13 nTPM
- medulla oblongata: 12 nTPM
- midbrain: 11 nTPM
- white matter: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.04
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ERK1 and ERK2 cascade
- G1/S transition of mitotic cell cycle
- negative regulation of activated T cell proliferation
- negative regulation of cytokine production
- negative regulation of ERK1 and ERK2 cascade
- negative regulation of G1/S transition of mitotic cell cycle
- negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- negative regulation of T cell receptor signaling pathway
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of regulatory T cell differentiation
- regulation of cytokine production
- T cell receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- B30.2/SPRY domain
- Immunoglobulin domain subtype
- SPRY domain
- Butyrophylin-like, SPRY domain
- SPRY-associated
- Immunoglobulin-like domain
- Immunoglobulin V-set domain
- Concanavalin A-like lectin/glucanase domain superfamily
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- Butyrophilin subfamily 1/2, SPRY/PRY domain
- B30.2/SPRY domain superfamily
- BTN/MOG-like
- Butyrophilin subfamily 3 member A2-like, Ig-C domain
- SPRY domain
- Immunoglobulin V-set domain
- SPRY-associated domain
- Butyrophilin subfamily 3 member A2-like, Ig-C domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BTN2A2 as an antibody target. Whether an autoantibody or antibody against BTN2A2 could matter depends on whether native BTN2A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BTN2A2 is annotated at the cell surface, where native BTN2A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label BTN2A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...